Latest Period
Q1 2026
Security Snapshot
Medpace Holdings, Inc. - Common Stock (MEDP) Institutional Ownership
CUSIP: 58506Q109
13F Institutional Holders and Ownership History from Q3 2016 to Q2 2026
Institutions Reporting
727
Shares (Excl. Options)
24,091,827
Price
$480.19
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- MEDP on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 24,091,827
- Total 13F value
- $11,541,666,761
- Portfolio coverage rank
- 0.01%
- Share change
- +313,497
- Value change
- +$98,257,245
- Number of holders
- 727
- Shares outstanding
- 28,414,670
- SEC-reported price per share
- $529.59
- Insider filing price
- $529.59
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MEDP - Medpace Holdings, Inc. - Common Stock is tracked under CUSIP 58506Q109.
- 727 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 727 to 41 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $11,541,666,761 to $503,244,718.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 727 institutions filings for Q1 2026.
Security key
58506Q109
Latest holder period
Q1 2026
13F holders
727
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
MEDP full holder history
Medpace Holdings, Inc. SEC filings
Medpace Holdings, Inc. company facts
Medpace Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 58506Q109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
MEDP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Troendle August J. | 20% | +2.5% | $3,389,756,472 | -$200,043,884 | 5,682,934 | -5.6% | August J. Troendle | 26 Nov 2025 |
As of 31 Mar 2026, 727 institutional investors reported holding 24,091,827 shares of Medpace Holdings, Inc. - Common Stock (MEDP). This represents 85% of the company’s total 28,414,670 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.7% | 2,470,440 | +2.4% | 0.02% | $1,186,280,656 |
| AQR CAPITAL MANAGEMENT LLC | 4.8% | 1,353,837 | +0.31% | 0.29% | $633,595,716 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9% | 1,121,689 | 0% | 0.03% | $538,623,841 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 1,011,071 | 0% | 0.01% | $485,506,183 |
| WASATCH ADVISORS LP | 2.7% | 773,931 | +19% | 2.5% | $371,633,927 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 745,106 | +12% | 0.02% | $357,841,964 |
| STATE STREET CORP | 2.4% | 682,229 | +2.6% | 0.01% | $327,599,544 |
| Invesco Ltd. | 2% | 577,574 | +20% | 0.04% | $277,345,259 |
| RENAISSANCE TECHNOLOGIES LLC | 1.8% | 504,668 | +8.3% | 0.38% | $242,336,527 |
| BAILLIE GIFFORD & CO | 1.8% | 503,191 | -8% | 0.25% | $241,627,287 |
| Mawer Investment Management Ltd. | 1.6% | 446,104 | +9.5% | 1.4% | $214,214,680 |
| D. E. Shaw & Co., Inc. | 1.5% | 432,602 | -18% | 0.16% | $207,731,154 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.4% | 395,769 | +5.5% | 0.1% | $190,044,316 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 348,485 | -3% | 0.03% | $167,300,348 |
| UBS Group AG | 1.2% | 340,433 | +3.5% | 0.03% | $163,472,522 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1% | 289,507 | +148% | 0.02% | $139,020,000 |
| MORGAN STANLEY | 1% | 288,422 | -31% | 0.01% | $138,498,033 |
| BESSEMER GROUP INC | 1% | 285,431 | -10% | 0.22% | $137,060,000 |
| Madison Asset Management, LLC | 0.92% | 262,293 | -5.6% | 1.6% | $125,950,423 |
| Giverny Capital Inc. | 0.9% | 256,081 | -2.7% | 4.5% | $122,967,535 |
| RIVERBRIDGE PARTNERS LLC | 0.84% | 237,407 | -13% | 2.8% | $114,000,563 |
| Thrivent Financial for Lutherans | 0.81% | 231,492 | +85% | 0.21% | $111,160,000 |
| NORTHERN TRUST CORP | 0.8% | 226,280 | +3.4% | 0.01% | $108,657,394 |
| AMERICAN CAPITAL MANAGEMENT INC | 0.77% | 217,947 | -2.9% | 5.6% | $104,655,970 |
| BANK OF AMERICA CORP /DE/ | 0.75% | 212,183 | +0.71% | 0.01% | $101,888,155 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
40
Latest
Q1 2026
Rows shown
1-25 of 40
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 950,138 | $503,244,718 | -$205,331,906 | $529.59 | 41 |
| 2026 Q1 | 24,091,827 | $11,541,666,761 | +$98,257,245 | $480.19 | 727 |
| 2025 Q4 | 23,756,826 | $13,342,638,324 | -$48,277,465 | $561.65 | 782 |
| 2025 Q3 | 23,962,730 | $12,312,326,556 | -$1,133,211,025 | $514.16 | 668 |
| 2025 Q2 | 26,383,560 | $8,288,435,409 | +$333,924,731 | $313.86 | 594 |
| 2025 Q1 | 25,351,494 | $7,718,802,423 | -$9,540,540 | $304.69 | 578 |
| 2024 Q4 | 25,340,363 | $8,420,105,198 | +$2,781,687 | $332.23 | 584 |
| 2024 Q3 | 25,315,006 | $8,458,156,137 | -$55,147,913 | $333.80 | 577 |
| 2024 Q2 | 25,134,495 | $10,351,346,830 | -$31,621,959 | $411.85 | 617 |
| 2024 Q1 | 25,247,742 | $10,201,457,017 | +$309,719,146 | $404.15 | 585 |
| 2023 Q4 | 24,605,167 | $7,542,681,992 | +$229,825,667 | $306.53 | 537 |
| 2023 Q3 | 23,978,527 | $5,807,458,403 | -$1,302,082 | $242.13 | 482 |
| 2023 Q2 | 23,852,532 | $5,728,812,297 | -$189,263,357 | $240.17 | 457 |
| 2023 Q1 | 24,865,090 | $4,674,846,132 | +$108,498,439 | $188.05 | 412 |
| 2022 Q4 | 24,347,700 | $5,172,004,976 | -$300,121,456 | $212.41 | 415 |
| 2022 Q3 | 25,865,491 | $4,065,022,806 | -$87,591,355 | $157.17 | 341 |
| 2022 Q2 | 26,319,125 | $3,938,916,557 | -$138,934,775 | $149.67 | 328 |
| 2022 Q1 | 27,353,541 | $4,474,335,613 | -$288,675,997 | $163.59 | 336 |
| 2021 Q4 | 28,637,675 | $6,230,873,750 | -$17,998,983 | $217.64 | 378 |
| 2021 Q3 | 28,619,666 | $5,416,650,219 | +$197,797,063 | $189.28 | 330 |
| 2021 Q2 | 27,593,763 | $4,873,907,764 | -$68,366,795 | $176.63 | 319 |
| 2021 Q1 | 27,985,360 | $4,594,004,259 | +$104,275,194 | $164.05 | 312 |
| 2020 Q4 | 27,673,447 | $3,850,051,602 | +$93,810,402 | $139.20 | 307 |
| 2020 Q3 | 27,120,457 | $3,030,671,185 | -$135,168,695 | $111.75 | 304 |
| 2020 Q2 | 28,380,989 | $2,639,244,485 | +$14,303,231 | $93.02 | 267 |